CorMedix Inc. - Common Stock (CRMD)

CUSIP: 21900C308

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
79,310,345
Total 13F shares
34,151,234
Share change
+10,225,008
Total reported value
$420,699,898
Put/Call ratio
65%
Price per share
$12.32
Number of holders
169
Value change
+$142,837,808
Number of buys
110
Number of sells
48

Quarterly Holders Quick Answers

What is CUSIP 21900C308?
CUSIP 21900C308 identifies CRMD - CorMedix Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CRMD - CorMedix Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13D/G 13F
Company
7.5%
4,567,897
$41,659,221 $0 31 Dec 2024
VANGUARD GROUP INC
13F
Company
4.6%
3,646,551
$22,462,755 31 Mar 2025
13F
Elliott Investment Management L.P.
13F
Company
3.1%
2,444,561
$15,058,496 31 Mar 2025
13F
STATE STREET CORP
13F
Company
1.9%
1,539,123
$9,480,998 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.8%
1,432,919
$8,828,592 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0.89%
703,740
$4,335,040 31 Mar 2025
13F
UBS Group AG
13F
Company
0.76%
602,534
$3,711,609 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
0.65%
516,517
$3,181,744 31 Mar 2025
13F
OBERWEIS ASSET MANAGEMENT INC/
13F
Company
0.61%
485,000
$2,987,600 31 Mar 2025
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
0.51%
404,231
$2,490,063 31 Mar 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.47%
371,126
$2,286,136 31 Mar 2025
13F
Palisades Investment Partners, LLC
13F
Company
0.45%
358,970
$2,211,040 31 Mar 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.41%
322,350
$1,985,676 31 Mar 2025
13F
Invesco Ltd.
13F
Company
0.36%
289,110
$1,780,918 31 Mar 2025
13F
Nuveen, LLC
13F
Company
0.35%
274,681
$1,692,035 31 Mar 2025
13F
Swedbank AB
13F
Company
0.32%
250,000
$1,540,000 31 Mar 2025
13F
ExodusPoint Capital Management, LP
13F
Company
0.29%
231,467
$1,426,000 31 Mar 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
0.29%
230,602
$1,420,508 31 Mar 2025
13F
MARSHALL WACE, LLP
13F
Company
0.29%
230,525
$1,420,034 31 Mar 2025
13F
Erin Mistry
3/4/5
EVP, Chief Commercial Officer
mixed-class rows
200,992
mixed-class rows
$1,130,100 10 Jan 2025
GOLDMAN SACHS GROUP INC
13F
Company
0.23%
179,798
$1,107,556 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.22%
177,188
$1,091,478 31 Mar 2025
13F
Spinnaker Capital LLC
13F
Company
0.22%
175,384
$1,080,000 31 Mar 2025
13F
David Matthew T.
3/4/5
Chief Financial Officer
mixed-class rows
195,270
mixed-class rows
$1,066,071 10 Jan 2025
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.21%
163,949
$1,009,926 31 Mar 2025
13F
Steward Partners Investment Advisory, LLC
13F
Company
0.2%
159,637
$983,364 31 Mar 2025
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.19%
153,763
$947,180 31 Mar 2025
13F
Bank of New York Mellon Corp
13F
Company
0.18%
143,238
$882,347 31 Mar 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0.18%
140,755
$867,051 31 Mar 2025
13F
Trexquant Investment LP
13F
Company
0.17%
135,487
$834,600 31 Mar 2025
13F
Wingate Wealth Advisors, Inc.
13F
Company
0.16%
126,015
$776,252 31 Mar 2025
13F
Qube Research & Technologies Ltd
13F
Company
0.16%
123,500
$760,760 31 Mar 2025
13F
Swiss National Bank
13F
Company
0.15%
117,600
$724,416 31 Mar 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.15%
115,400
$710,864 31 Mar 2025
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.14%
113,686
$700,000 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.13%
105,970
$652,775 31 Mar 2025
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.13%
105,676
$650,964 31 Mar 2025
13F
Graham Capital Management, L.P.
13F
Company
0.13%
105,194
$647,995 31 Mar 2025
13F
GROUP ONE TRADING LLC
13F
Company
0.11%
90,218
$555,743 31 Mar 2025
13F
BARCLAYS PLC
13F
Company
0.11%
87,791
$540,791 31 Mar 2025
13F
Private Advisor Group, LLC
13F
Company
0.11%
85,509
$526,731 31 Mar 2025
13F
RHUMBLINE ADVISERS
13F
Company
0.1%
81,565
$502,426 31 Mar 2025
13F
Squarepoint Ops LLC
13F
Company
0.08%
66,420
$409,147 31 Mar 2025
13F
LPL Financial LLC
13F
Company
0.08%
60,567
$373,093 31 Mar 2025
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.07%
59,323
$365,430 31 Mar 2025
13F
CITIGROUP INC
13F
Company
0.07%
57,624
$354,964 31 Mar 2025
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.07%
57,268
$352,771 31 Mar 2025
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.07%
56,675
$349,118 31 Mar 2025
13F
Legal & General Group Plc
13F
Company
0.07%
53,465
$329,155 31 Mar 2025
13F
WOLVERINE TRADING, LLC
13F
Company
0.06%
45,937
$309,615 31 Mar 2025
13F

Institutional Holders of CorMedix Inc. - Common Stock (CRMD) as of Q2 2025

As of 30 Jun 2025, CorMedix Inc. - Common Stock (CRMD) was held by 169 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,151,234 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, MARSHALL WACE, LLP, CITADEL ADVISORS LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Nuveen, LLC, MORGAN STANLEY, Alyeska Investment Group, L.P., and Ghisallo Capital Management LLC. This page lists 170 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
135
Q2 2025 holders
169
Holder diff
34
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.